Health Trials

Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of B007 in the Treatment of Pemphigus.

The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with pemphigus.

Participants needed: 132
Trial details
Phase: Phase 2, Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: May 5, 2026Locations: 12
Eligibility criteria

Subjects who voluntarily participate in this study and sign informed consent for... [+3]

Subjects diagnosed with prescribed diseases; [+11]

Read more
Status: Recruiting

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy

Participants needed: 216
Trial details
Phase: Phase 2, Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: May 5, 2026Locations: 21
Eligibility criteria

Subjects with primary membranous nephropathy pathologically confirmed by renal b... [+6]

Subjects with secondary membranous nephropathy or primary membranous nephropathy... [+11]

Read more
Status: Recruiting

A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.

To evaluate the efficacy and safety of B013 in patients with platinum-resistant recurrent ovarian cancer.

Participants needed: 90
Trial details
Phase: Phase 2Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: May 5, 2026Locations: 17
Eligibility criteria

Subjects who voluntarily participate in this study and sign informed consent for... [+6]

Subjects who have received prescribed treatment previously; [+14]

Read more
Status: Recruiting

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with generalized myasthenia gravis.

Participants needed: 104
Trial details
Phase: Phase 2, Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: Apr 30, 2026Locations: 18
Eligibility criteria

Sign informed consent form; [+5]

Subjects with MGFA I and V type; [+11]

Read more
Status: Recruiting

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

To evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.

Participants needed: 132
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: May 5, 2026Locations: 51
Eligibility criteria

Confirmed NMOSD patients; [+3]

Subjects with severe NMOSD were judged by the researcher to be unfit to particip... [+18]

Read more
Status: Recruiting

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles and Preliminary Efficacy of Subcutaneous Injection of Recombinant Humanized Anti-CD20 Monoclonal Antibody in the Treatment of Primary Membranous Nephropathy

Participants needed: 52
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Jiaolian Drug Research and Development Co., LtdUpdated: Apr 30, 2026Locations: 6
Eligibility criteria

Subjects who have fully understood this study and voluntarily signed the informe... [+5]

Subjects with secondary membranous nephropathy; [+14]

Read more